Health Canada to start real-time review of Pfizer-BioNTech COVID-19 vaccine

(Reuters) - Health Canada will launch a real-time review of Germany’s BioNTech SE and Pfizer Inc.’s experimental COVID-19 vaccine on Friday.
The companies said they would provide the Canadian Department of Health with safety and efficacy data from their COVID-19 vaccine trial as an ongoing filing when it becomes available.
Continuous review allows researchers to submit results in real time without waiting for studies to complete. Canadian Health Minister Patty Hajdu signed an ordinance last month that allows companies developing COVID-19 vaccines to submit information as soon as it becomes available.
Health Canada said it would not make a decision on whether to approve a vaccine that is undergoing ongoing review until it has received the necessary evidence to demonstrate the candidate's safety, effectiveness and quality.
The EU health authority on Tuesday launched a real-time review of the companies' experimental COVID-19 vaccine, potentially speeding up the process of getting a vaccine approved.
The Canadian Department of Health began a real-time review of the vaccine candidate from AstraZeneca and Oxford University a week ago to expedite the potential approval of a COVID-19 vaccine. (

(Reporting by Trisha Roy in Bengaluru; editing by Shinjini Ganguli)

You should check here to buy the best price guaranteed products.

Last News

10 Best Healthy Breakfast Foods to Buy at Costco, According to a Dietitian

Britney Spears asks judge to end conservatorship, saying: "I just want my life back"

Heartbreaking images capture the Surfside building collapse and rescue efforts

It's not a slam dunk for Jerome Powell to get a second term: strategist

Britney Spears Reveals She Was Forced To Take Lithium, & It Affected Her In Unexpected Ways

Opinion: By dismissing QB recruit Kaidon Salter, Tennessee coach Josh Heupel sends big message